| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |